Belarus vs Tonga: The number of people with susceptibility test result for rifampicin
Belarus
100
in 2021
Tonga
100
in 2021
Belarus rank
2nd
Tonga rank
2nd
The number of people with susceptibility test result for rifampicin over time
- Belarus
- Tonga
How they compare
Belarus currently reports 100 against 100 in Tonga, a difference of 0.
Across all 5 years both countries report, Tonga has been ahead every year.
Belarus ranks 2nd and Tonga ranks 2nd of 146 countries.
Head to head by decade
| Decade | Belarus | Tonga | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 100 | 100 | 0 | — |
| 2020s | 100 | 100 | 0 | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Belarus or Tonga?
- Belarus, at 100 against 100 in Tonga as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Belarus and Tonga?
- 0, with Belarus ahead.
- How many years of comparable data are there for Belarus and Tonga?
- 5 years are reported by both, from 2017 to 2021.
- How do Belarus and Tonga rank globally for the number of people with susceptibility test result for rifampicin?
- Belarus ranks 2nd and Tonga ranks 2nd of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.